Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin

S E Wilson; J A Boswick Jr; R J Duma; R M Echols; J G Jemsek; R Lerner; R T Lewis; A Z Najem; R A Press; M S Rittenbury

doi:10.1016/s0002-9610(88)80215-0

Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin

Am J Surg. 1988 May 31;155(5A):61-6. doi: 10.1016/s0002-9610(88)80215-0.

Authors

S E Wilson¹, J A Boswick Jr, R J Duma, R M Echols, J G Jemsek, R Lerner, R T Lewis, A Z Najem, R A Press, M S Rittenbury, et al.

Affiliation

¹ Department of Surgery, Harbor-UCLA Medical Center, Torrance.

PMID: 3287971
DOI: 10.1016/s0002-9610(88)80215-0

Abstract

Three broad-spectrum cephalosporins (cefotetan, moxalactam, and cefoxitin) proved effective in this randomized, prospective trial for treatment of 303 surgical patients with moderately severe regional peritonitis.

Publication types

Clinical Trial
Comparative Study
Randomized Controlled Trial

MeSH terms

Bacterial Infections / drug therapy*
Cefotetan
Cefoxitin / therapeutic use*
Cephamycins / therapeutic use*
Clinical Trials as Topic
Humans
Moxalactam / therapeutic use*
Peritonitis / drug therapy*
Prospective Studies
Random Allocation
Time Factors

Substances

Cephamycins
Cefotetan
Cefoxitin
Moxalactam